Novartis Irish pre-tax profits rise to €4.2m

PRE-TAX profits at the Irish sales arm of pharmaceutical company Novartis last year increased by 6% to €4.2 million.

Accounts just returned to the Companies Office show that Novartis Ireland Ltd’s pharmaceutical’s sale revenues increased by 7% from €59.9m to €64.3m, while group turnover increased by 1%, from €63.5m to €64.3m to the end of December last.

The directors’ report states that turnover was driven by increased demand, particularly in the cardiovascular, oncology and respiratory sectors.